Biblio

Fei C-M, Gu S-C, Zhao Y-S, Guo J, Li X, Chang C-K. [Osteogenic Differentiation Potential of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23(3):750-755.

• PubMed
• Google Scholar

Xu F, Li X, Chang C-K, Guo J, Wu L-Y, He Q, Zhang Z, Zhu Y, Gu S-C, Shi W-H, et al. Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes. PLoS One. 2014;9(2):e88706.

• PubMed
• Google Scholar

Xu L, Gu Z-H, Li Y, Zhang J-L, Chang C-K, Pan C-M, Shi J-Y, Shen Y, Chen B, Wang Y-Y, et al. Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers. Proc Natl Acad Sci U S A. 2014.

• PubMed
• Google Scholar